Several human inhibitor of apoptosis (IAP) family proteins function by directly inhibiting specific caspases in a mechanism that does not require IAP cleavage. In this study, however, we demonstrate that endogenous XIAP is cleaved into two fragments during apoptosis induced by the tumor necrosis factor family member Fas (CD95). The two fragments produced comprise the baculoviral inhibitory repeat (BIR) 1 and 2 domains (BIR1‐2) and the BIR3 and RING (BIR3‐Ring) domains of XIAP. Overexpression of the BIR1‐2 fragment inhibits Fas‐induced apoptosis, albeit at significantly reduced efficiency compared with full‐length XIAP. In contrast, overexpression of the BIR3‐Ring fragment results in a slight enhancement of Fas‐directed apoptosis. Thus, cleavage of XIAP may be one mechanism by which cell death programs circumvent the anti‐apoptotic barrier posed by XIAP. Interestingly, ectopic expression of the BIR3‐Ring fragment resulted in nearly complete protection from Bax‐induced apoptosis. Use of purified recombinant proteins revealed that BIR3‐Ring is a specific inhibitor of caspase‐9 whereas BIR1‐2 is specific for caspases 3 and 7. Therefore XIAP possesses two different caspase inhibitory activities which can be attributed to distinct domains within XIAP. These data may provide an explanation for why IAPs have evolved with multiple BIR domains.
The EMBO Journal – Wiley
Published: Oct 1, 1999
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera